/Investor DB

Seyen Capital — 2023 Investments

4 investments dated 2023 · listed companies and verified rows first · show all

Hucuhucu.aiin𝕏Oct 2023

Hucu.ai is a healthcare technology company founded by experienced executives in digital health and AI.

AI & Machine LearningDigital HealthHealthtechSaaSChicago, US

Asif Khan(Co-founder & CEO)inLaura McKee(Co-Founder & President)inMudaser Ali(Co-Founder, Lead Engineer)VIC GATTO(Manager of Issuer)GEORGE SPENCER(Manager of Issuer)

Co-investorsJumpstart Capital

Pear TherapeuticsinDec 2023 · $20MDefunct

Pioneering the development of prescription digital therapeutics.

HealthtechBoston, US

Corey McCann(Executive Officer, Director)inAntoun Nabhan(Executive Officer)Christopher Guiffre(Executive Officer)

BoardAndrew Schwab(Director)inTimothy Petersen(Director)inZack Lynch(Director)in

Co-investorsJAZZ Venture Partners5AM VenturesArboretum VenturesGeneral CatalystOCA VenturesSoftBank Group+2 more

PursueCarepursuecare.comin𝕏Dec 2023 · $20M

PursueCare provides addiction treatment and mental health services designed to increase accessibility to comprehensive care.

Digital HealthHealthtechMental HealthMiddletown, US

Nicholas Mercadante(CEO & Founder)inEd Mercadante, RPh, ScD(Co-Founder)Thomas Menighan, R.Ph, Sc.D(Co-founder)in

Co-investorsAdvection Growth CapitalConnecticut InnovationsYamaha Motor VenturesOCA Ventures

T.Rx Capitaltrxcap.cominDec 2023

T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.

BiotechDigital HealthMedical Devices

Kwesi Frimpong-Boateng(Co-founder & Managing Partner)inMichael Langer(Co-founder & Managing Partner)inCorey M. McCann(Co-founder & Managing Partner)inRobert Langer(Executive Chairman & Chair of Scientific Advisory Board)

Co-investorsModi VenturesOCA VenturesYamaha Motor Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.